Comparable effectiveness using flexible single-dose GnRH antagonist (cetrorelix) and single-dose long GnRH agonist (goserelin) protocol for IVF cycles - a prospective, randomized study

By Vlaisavljevic Veljko   Reljic Milan   Lovrec Vida Gavric   Kovacic Borut  

Reproductive BioMedicine Online, Vol. 7, Iss. 3, 2003-10 ,pp. : 301-308

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Luteal phase characteristics following GnRH antagonist or agonist treatment – a comparative study

By Friedler Shevach   Gilboa Sarit   Schachter Morey   Raziel Arieh   Strassburger Devorah   Ron El Raphael  

Reproductive BioMedicine Online, Vol. 12, Iss. 1, 2006-01 ,pp. : 27-32

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

A prospective randomized study comparing coasting with GnRH antagonist administration in patients at risk for severe OHSS

By Aboulghar Mohamed A   Mansour Ragaa T   Amin Yahia M   Al-Inany Hesham G   Aboulghar Mona M   Serour Gamal I  

Reproductive BioMedicine Online, Vol. 15, Iss. 3, 2007-09 ,pp. : 271-279

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix, 3 mg) in patients undergoing assisted reproduction treatment

By Roulier Roger   Chabert-Orsini Véronique   Sitri Marie-Christine   Barry Bernard   Terriou P  

Reproductive BioMedicine Online, Vol. 7, Iss. 2, 2003-09 ,pp. : 185-189

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Case Report: Live births after management of severe OHSS by GnRH antagonist administration in the luteal phase

By Lainas TG   Sfontouris IA   Zorzovilis IZ   Petsas GK   Lainas GT   Alexopoulou E   Kolibianakis EM  

Reproductive BioMedicine Online, Vol. 19, Iss. 6, 2009-12 ,pp. : 789-795

Reproductive Healthcare Ltd

Access to resources Recommend Favorite